A detailed history of Steward Partners Investment Advisory, LLC transactions in Organon & Co. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 11,161 shares of OGN stock, worth $162,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,161
Previous 6,335 76.18%
Holding current value
$162,727
Previous $131,000 62.6%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $90,004 - $111,142
4,826 Added 76.18%
11,161 $213,000
Q2 2024

Aug 08, 2024

BUY
$17.45 - $21.96 $23,435 - $29,492
1,343 Added 26.9%
6,335 $131,000
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $6,848 - $9,343
-497 Reduced 9.05%
4,992 $93,000
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $25,097 - $39,697
-2,292 Reduced 29.46%
5,489 $79,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $6,453 - $9,246
-389 Reduced 4.76%
7,781 $135,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $173 - $221
9 Added 0.11%
8,170 $170,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $20,627 - $30,893
-963 Reduced 10.55%
8,161 $191,000
Q4 2022

Feb 15, 2023

SELL
$23.31 - $28.61 $22,843 - $28,037
-980 Reduced 9.7%
9,124 $254,000
Q3 2022

Nov 10, 2022

SELL
$23.4 - $34.25 $118,872 - $173,990
-5,080 Reduced 33.46%
10,104 $236,000
Q2 2022

Aug 04, 2022

SELL
$31.66 - $38.9 $38,941 - $47,847
-1,230 Reduced 7.49%
15,184 $512,000
Q1 2022

May 02, 2022

SELL
$30.45 - $39.36 $61,326 - $79,271
-2,014 Reduced 10.93%
16,414 $573,000
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $203,528 - $263,585
-7,099 Reduced 27.81%
18,428 $561,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $106,789 - $132,937
-3,730 Reduced 12.75%
25,527 $837,000
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $832,361 - $1.11 Million
29,257 New
29,257 $885,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.